Study shows feasibility of blood-based test for diagnosing Alzheimer's Disease

March 11, 2015

UCLA researchers have provided the first evidence that a simple blood test could be developed to confirm the presence of beta amyloid proteins in the brain, which is a hallmark of Alzheimer's disease.

Although approximately 5 million Americans are living with Alzheimer's, no reliable blood-based test currently exists for the neurodegenerative disorder that is the sixth-leading cause of death in the United States. Using blood-based biomarkers—a signature of proteins in the blood that indicate the presence of a disease—to diagnose Alzheimer's could be a key advance.

Read the full story.